Similar articles

• Protection by desipramine of 6-hydroxydopamine induced damage to adrenergic nerve terminals in mouse heart.

  Bonagura V, Cassebaum L, Dangman K, Freund J, Cabbat F, Dembiec D, Heikkila R, Cohen G. Bonagura V, et al. Res Commun Chem Pathol Pharmacol. 1972 Jul;4(1):163-71. Res Commun Chem Pathol Pharmacol. 1972. PMID: 4671960 No abstract available.
• Rapid recovery of vascular adrenergic nerves in the rat after chemical sympathectomy with 6-hydroxydopamine.

  Finch L, Haeusler G, Kuhn H, Thoenen H. Finch L, et al. Br J Pharmacol. 1973 May;48(1):59-72. doi: 10.1111/j.1476-5381.1973.tb08222.x. Br J Pharmacol. 1973. PMID: 4724194 Free PMC article.
• Evidence for degeneration of sympathetic nerve terminals caused by the ortho- and para-quinones of 6-hydroxydopamine.

  Heikkila RE, Mytilineou C, Côté L, Cohen G. Heikkila RE, et al. J Neurochem. 1973 May;20(5):1345-50. doi: 10.1111/j.1471-4159.1973.tb00246.x. J Neurochem. 1973. PMID: 4716829 No abstract available.
• The pharmacology of 6-hydroxydopamine.

  Thoenen H, Tranzer JP. Thoenen H, et al. Annu Rev Pharmacol. 1973;13:169-80. doi: 10.1146/annurev.pa.13.040173.001125. Annu Rev Pharmacol. 1973. PMID: 4576887 Review. No abstract available.
• The uptake, storage, release and metabolism of noradrenaline in sympathetic nerves.

  Axelrod J, Kopin IJ. Axelrod J, et al. Prog Brain Res. 1969;31:21-32. doi: 10.1016/S0079-6123(08)63224-0. Prog Brain Res. 1969. PMID: 4900113 Review. No abstract available.